Clinical Trials
Providence Brain Institute is involved in several clinical trials for investigational medications for stroke, multiple sclerosis, Alzheimer’s disease and more. For information on the trials, please review the summaries and links below.
Multiple sclerosis
Providence Multiple Sclerosis Center seeks patients for multiple investigational MS medications.
Stroke
Providence Stroke Center seeks patients for two clinical trials. The first is for an investigational medication to help prevent further heart attacks or stroke in people with atherosclerotic disease. The second involves a study on hospitalized patients who experienced an intraventricular hemorrhage.
Alzheimer's disease
A phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety trial of bapineuzumab (AAB-001, ELN115727) in subjects with mild to moderate Alzheimer’s disease who are apolipoprotein Ee4 carriers.
Sponsor: Elan Pharmaceuticals Inc.
Principal investigator: Michael Mega, M.D., Ph.D.
Amyotrophic lateral sclerosis (ALS)
A multicenter study for the validation of ALS biomarkers to help diagnosis. For more information, call Kimberly Goslin, M.D., Providence ALS Center, 503-963-3100.
|
